China's agriculture ministry issued guidelines on Friday to promote biotech cultivation from 2024 to 2028, a ministry ...

Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index ...

U.S. investors and pharmaceutical giants are increasingly looking to China for drug innovation, with nearly 30% of major pharma deals last year involving Chinese companies—up from 0% in 2019.

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of ...

People with motor neuron disease should be allowed to say whatever they want, including “arse” and “knickers.” ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Health scientists and drug industry executives around the world are on alert after the confirmation of Robert F. Kennedy Jr., who spreads antivaccine misinformation and has often derided the ...

Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...